Document Type : Original Article
Authors
1 Department of Pharmacy, Jodhpur National University, Jodhpur, Rajasthan, India
2 Department of Pharmacy, Pranveer Singh Institute of Technology, Bhauti Road, Kanpur, Uttar Pradesh, India
3 Department of Medicine, LPS (Lakshmi Pat Singhania) Institute of Cardiology, Kanpur, Uttar Pradesh, India
Abstract
Objective: The main objective of this study was to assess the effects of pharmaceutical
care interventions in patients with essential hypertension in Lakshmi Pat Singhania Institute
of Cardiology, Kanpur, India.
Methods: The study was carried out from July 2010 to August 2011. Pharmaceutical care
was provided for 54 patients (intervention group) which was comprised of the patient
education, the prescription assistance and the life style modifications and motivation for
health. Then the clinical outcome as well as health related quality of life (HRQOL) were
compared with the control group (48 patients) in which the pharmaceutical care was not
provided. Furthermore, the effect of pharmaceutical care intervention on HRQOL was
assessed using Short Form‑36 (SF‑36), a general health related quality of life questionnaire
used to evaluate the QOL of patients. Blood pressure (BP) measurements and QOL survey
was performed at baseline and at the follow‑up session.
Findings: The difference between blood pressure readings from the baseline to the second
follow‑up was significant for systolic [(P = 0.0001), 12.24 mmHg] and diastolic BP [(P = 0.001),
5.17 mmHg] in the intervention group. The questionnaire used to evaluate the QOL of
patients also showed improvement in the mean score for intervention group.
Conclusion: Results from our study showed that applying pharmaceutical care to
hypertensive patients can help in the control of these patients’ blood pressure, and
consequently lower the risk that hypertension poses in cardiovascular disease. Successful
implementation of pharmaceutical care has the potential to increase patients’ satisfaction
with their pharmacists’ activities and may increase patients’ expectations that pharmacists
will work on their behalf to assist them with their healthcare needs.
Keywords
Everard M, Tromp D. The definition of Pharmaceutical
care in Developing pharmacy practice, A focus on patient
care. Geneva. World Health Organization and International
Pharmaceutical Federation; 2006.
2. Saseen JJ, Carter BL. Hypertension. In: Dipiro JT, Talbert RL,
Yee GC, Matzke GR, Wells BG, Posey LM, editors.
Pharmacotherapy‑ A pathophysiologic approach, 6th ed.
Newyork: McGraw‑Hill Companies; 2005. p. 185‑218.
3. Kearney PM, WheltonM, Reynolds K, Muntner P, Whelton PK,
He J. Global burden of hypertension: Analysis of worldwide
data. Lancet 2005;365:217‑23.
4. Lawes CM, Vander SH, Law MR, Elliott P, MacMahon S,
Rodgers A. Blood pressure and the global burden of disease
2000. Part II: Estimates of attributable burden. J Hypertens
2006;24:423‑30.
5. Brian BH. Therapy of hypertension. In: Laurance LB, John SL,
Keith LP, editors. Goodman and Gilman’s the pharmacological
Basis of therapeutics. 11th ed. New York: McGraw Hill; 2005
p. 845.
6. Libby EA, Laub JJ. Economic and clinical impact of a pharmacy
based antihypertensive replacement programme in primary
care. Am J Health Syst Pharm 1997;54:2079‑83.
7. de Lyra DP, Kheir N, Abriata JP, da Rocha CE, Dos Santos CB,
Pelá IR. Impact of Pharmaceutical Care interventions in the
identification and resolution of drugrelated problems and
on quality of life in a group of elderly outpatients in Ribeirão
Preto (SP), Brazil. Ther Clin Risk Manag 2007;3:989‑98.
8. Sookaneknun P, Richard ME, Sanguansermsri J, Teerasut C.
Pharmacist involvement in Primary Care Improves
Hypertensive Patient Clinical Outcome. Ann Pharmacother
2004;38:2023‑8.
9. Garcao JA, Cabrita J. Evaluation of a pharmaceutical care
program for hypertensive patients in rural Portugal. J Am
Pharm Assoc (Wash) 2002;42:858‑64.
10. Mancia G. Effective ambulatory blood pressure control in
medical practice. Hypertension 2007;49:17‑8.
11. Chamontin B, Poggi L, Lang T, Ménard J, Chevalier H,
Gallois H, et al. Prevelance, treatment, and control of
hypertension in the French population data from a survey
on high blood pressure in general practice. Am J Hypertens
1994;11:759‑62.
12. Vollmer WM, Sacks FM, Ard J, Appel LJ, Bray GA,
Simons‑Morton DG, et al. Effects of diet and sodium intake
on blood pressure: Subgroup analysis of the DASH – sodium
trial. Ann Intern Med 2001;135:1019‑28.
13. DroyvoldWB, Midthjell K, Nilsen T, Holmen J. Change in body
mass index and its impact on blood pressure: A prospective
population study. Int J Obes (Lond) 2005;29:650‑5.
14. Carter BL, Billich AJ, Elliott WJ. How pharmacist can
assist physicians with controlling blood pressure. J Clin
Hypertens (Greenwich) 2003;5:31‑7.
15. Erickson SR, Slaughter R, Halapy H. Pharmacists’ ability to
influence outcomes of hypertension therapy. Pharmacotherapy
1997;17:140‑7.
16. McKenney JM, Slining JM, Henderson HR, Devins D, Barr M.
The effect of clinical pharmacy services on patients with
essential hypertension. Circulation 1973;48:1104‑11.
17. Mehos BM, Saseen JJ, MacLaughlin EJ. Effect of pharmacist
intervention and initiation of home blood pressure monitoring
in patients with uncontrolled hypertension. Pharmacotherapy
2000;20:1384‑9.
18. Ni Y, Chen Y, Huang W. The Effect of Pharmaceutical
Care Programs on Blood Pressure Control in Individuals
with Hypertension: A Meta‑Analysis. J Pharm Technol
2009;25:292‑6.
19. Pickard AS, Johnson JA, Farris KB. The impact of pharmacist
interventions on health related quality of life. J Ann
Pharmacother 1999;33:1167‑72.
20. Park JJ, Kelly P, Carter BL, Burgess PP. Comprehensive pharmaceutical care in the chain setting. J Am Pharm
Assoc (Wash) 1996;36:443‑51.
21. Kusek JW, Lee JY, Smith DE, Milligan S, Faulkner M,
Cornell CE, et al. Effect of blood pressure control and
Antihypertensive drug regimen on quality of life: The African
American study of kidney disease and hypertension (AASK)
pilot study. Control Clin Trials 1996;16:40S‑6
)